| Year |
Citation |
Score |
| 2012 |
Mehrotra S, Al-Khami AA, Klarquist J, Husain S, Naga O, Eby JM, Murali AK, Lyons GE, Li M, Spivey ND, Norell H, Martins da Palma T, Onicescu G, Diaz-Montero CM, Garrett-Mayer E, et al. A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. Journal of Immunology (Baltimore, Md. : 1950). 189: 1627-38. PMID 22798675 DOI: 10.4049/Jimmunol.1103271 |
0.583 |
|
| 2010 |
Norell H, Zhang Y, McCracken J, Martins da Palma T, Lesher A, Liu Y, Roszkowski JJ, Temple A, Callender GG, Clay T, Orentas R, Guevara-Patiño J, Nishimura MI. CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. Cancer Immunology, Immunotherapy : Cii. 59: 851-62. PMID 20052466 DOI: 10.1007/S00262-009-0810-8 |
0.628 |
|
| 2009 |
Norell H, Martins da Palma T, Lesher A, Kaur N, Mehrotra M, Naga OS, Spivey N, Olafimihan S, Chakraborty NG, Voelkel-Johnson C, Nishimura MI, Mukherji B, Mehrotra S. Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death. Cancer Research. 69: 6282-9. PMID 19638595 DOI: 10.1158/0008-5472.Can-09-1176 |
0.566 |
|
| 2008 |
Ando T, Mimura K, Johansson CC, Hanson MG, Mougiakakos D, Larsson C, Martins da Palma T, Sakurai D, Norell H, Li M, Nishimura MI, Kiessling R. Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. Journal of Immunology (Baltimore, Md. : 1950). 181: 8382-90. PMID 19050255 DOI: 10.4049/Jimmunol.181.12.8382 |
0.62 |
|
| Show low-probability matches. |